Literature DB >> 6145877

Cancer cachexia and protein metabolism.

M Jeevanandam, G D Horowitz, S F Lowry, M F Brennan.   

Abstract

Metabolic abnormalities arising from malnutrition and malignancy are seen in patients with cancer cachexia. To discriminate between the effects of pure malnutrition and tumour-specific metabolic alterations, the kinetics of whole-body metabolism were determined in 7 untreated, malnourished cancer patients and in 11 patients with benign disease, also malnourished, by means of primed constant infusion of 15N-glycine. Patients in both groups received 500 kcal/day as 5% glucose solution without any nitrogen. Whole-body protein turnover was 32% and 35% higher in the cancer patients than in the non-cancer patients and starved normal subjects respectively. Similarly, the rate of protein synthesis was 35% and 54% higher in the cancer patients than in the non-cancer patients and starved normal subjects respectively. Our study supports the view that aberrations of host metabolism in patients with cancer cachexia are different from those in non-cancer patients suffering equivalent weight loss.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145877     DOI: 10.1016/s0140-6736(84)91929-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

Review 1.  Amino acid regulation of gene expression.

Authors:  P Fafournoux; A Bruhat; C Jousse
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

Review 2.  Metabolic alteration in patients with cancer: nutritional implications.

Authors:  Y Sakurai; S Klein
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  Metabolic effects of nutritional support to cancer patients.

Authors:  L Lindmark; L Ekman
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

4.  Glomerular hyperfiltration in children with cancer: prevalence and a hypothesis.

Authors:  Neha S Kwatra; Holly J Meany; Sunil J Ghelani; David Zahavi; Nayan Pandya; Massoud Majd
Journal:  Pediatr Radiol       Date:  2016-11-03

5.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.

Authors:  K J Tracey; S Morgello; B Koplin; T J Fahey; J Fox; A Aledo; K R Manogue; A Cerami
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy.

Authors:  H F Starnes; R S Warren; M F Brennan
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

7.  Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.

Authors:  Alan L Schneyer; Yisrael Sidis; Anisha Gulati; Jie L Sun; Henry Keutmann; Philip A Krasney
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

8.  Effect of growth hormone on tumor and host in an animal model.

Authors:  R F Wolf; B Ng; B Weksler; M Burt; M F Brennan
Journal:  Ann Surg Oncol       Date:  1994-07       Impact factor: 5.344

9.  Identification of a novel amino acid response pathway triggering ATF2 phosphorylation in mammals.

Authors:  Cédric Chaveroux; Céline Jousse; Yoan Cherasse; Anne-Catherine Maurin; Laurent Parry; Valérie Carraro; Benoit Derijard; Alain Bruhat; Pierre Fafournoux
Journal:  Mol Cell Biol       Date:  2009-10-12       Impact factor: 4.272

Review 10.  Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19.

Authors:  J Arends; G Zuercher; A Dossett; R Fietkau; M Hug; I Schmid; E Shang; A Zander
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.